1 week Ago By ABMN Staff
Pictet Asset Management Holding SA cut its stake in DENTSPLY SIRONA Inc. ( NASDAQ:XRAY – Free Report ) by 4.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.
The firm owned 38,665 shares of the medical instruments supplier’s stock after selling 1,727 shares during the quarter. Pictet Asset Management Holding SA’s holdings in DENTSPLY SIRONA were worth $734,000 as of its most recent filing with the Securities & Exchange Commission. Other hedge funds have also recently made changes to their positions in the company.
Riverview Trust Co bought a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB boosted its stake in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter.
MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 1,232 shares during the last quarter. UMB Bank n.a.
grew its holdings in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.
a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares during the period. Mitsubishi UFJ Asset Management Co.
Ltd. increased its position in DENTSPLY SIRONA by 700.0% during the fourth quarter.
Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 1,568 shares during the last quarter.
Finally, Quarry LP lifted its holdings in DENTSPLY SIRONA by 455.0% in the third quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock valued at $82,000 after acquiring an additional 2,489 shares during the period.
95.70% of the stock is owned by hedge funds and other institutional investors. DENTSPLY SIRONA Stock Performance XRAY opened at $13.
24 on Tuesday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.
84 and a current ratio of 1.25. The stock has a market capitalization of $2.
63 billion, a price-to-earnings ratio of -6.40, a PEG ratio of 1.80 and a beta of 0.
92. The company has a fifty day moving average of $17.01 and a 200 day moving average of $19.
61. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.
54 and a fifty-two week high of $33.02. DENTSPLY SIRONA Dividend Announcement Analysts Set New Price Targets Several equities research analysts have recently commented on XRAY shares.
Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and reduced their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd.
Morgan Stanley decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th.
Mizuho dropped their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research note on Thursday, March 13th.
Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th.
Finally, Barrington Research lowered their target price on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th.
Twelve equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average price target of $23.33.
Check Out Our Latest Stock Report on DENTSPLY SIRONA Insider Buying and Selling In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were bought at an average price of $16.
51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.
21. This trade represents a 22.66 % increase in their ownership of the stock.
The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website . 0.52% of the stock is owned by company insiders.
About DENTSPLY SIRONA ( Free Report ) DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter ..
